Krose 10 Gold Capsule is a combination pharmaceutical formulation containing Aspirin (75 mg), Rosuvastatin (10 mg), and Clopidogrel (75 mg), designed to manage and reduce the risk of cardiovascular events in patients with atherosclerotic cardiovascular disease or those at high risk of such conditions. Aspirin acts as an antiplatelet agent by irreversibly inhibiting cyclooxygenase-1 (COX-1), thereby reducing thromboxane A2 production and preventing platelet aggregation. Rosuvastatin, a potent HMG-CoA reductase inhibitor, lowers low-density lipoprotein cholesterol (LDL-C) and triglycerides while modestly increasing high-density lipoprotein cholesterol (HDL-C), contributing to plaque stabilization and reduction of cardiovascular risk. Clopidogrel, another antiplatelet agent, selectively inhibits the adenosine diphosphate (ADP) receptor on platelet cell membranes, further preventing platelet aggregation. The synergistic effect of these agents provides comprehensive cardiovascular protection by addressing multiple pathways involved in thrombosis and atherosclerosis. Krose 10 Gold Capsule is indicated for secondary prevention of myocardial infarction, stroke, and other thrombotic events in patients with established cardiovascular disease. It should be used under medical supervision with caution in patients with bleeding disorders, hepatic impairment, or those undergoing surgery. Regular monitoring of lipid profiles, liver function, and bleeding parameters is recommended during therapy.